Cargando…

Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice

BACKGROUND: Toxoplasmosis, caused by an obligate intracellular protozoan parasite Toxoplasma gondii, has been a serious clinical and veterinary problem. Effective DNA vaccines against T. gondii can prevent and control the spread of toxoplasmosis, which is important for both human health and the farm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Min, He, Shenyi, Zhao, Guanghui, Bai, Yang, Zhou, Huaiyu, Cong, Hua, Lu, Gang, Zhao, Qunli, Zhu, Xing-Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547689/ https://www.ncbi.nlm.nih.gov/pubmed/23181694 http://dx.doi.org/10.1186/1756-3305-5-273

Ejemplares similares

Compound DNA vaccine encoding SAG1/ SAG3 with A(2)/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii
por: Cong, Hua, et al.
Publicado: (2013)

DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice
por: Meng, Min, et al.
Publicado: (2013)

Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
por: Lu, Gang, et al.
Publicado: (2014)

A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection
por: Yin, Huiquan, et al.
Publicado: (2015)

Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Evaluation of Immunogenic Effect of Toxoplasma gondii Recombinant SAG-1 Antigen with Propranolol as Adjuvant in BALB/c Mice
por: Abasi, Esmaeil, et al.
Publicado: (2019)

Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii
por: Wang, Yanhua, et al.
Publicado: (2014)

DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice
por: Han, Yali, et al.
Publicado: (2017)

Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice
por: Han, Yali, et al.
Publicado: (2017)

Immunoreactivity Analysis of Toxoplasma gondii Recombinant Antigen rSAG3 in Sera from Immunized BALB/c Mice and Toxoplasmosis Patients
por: MOTAZEDIAN, Mohammad Hossein, et al.
Publicado: (2016)

Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice
por: Cong, Hua, et al.
Publicado: (2014)

Evaluation of Immunogenicity of Cocktail DNA Vaccine Containing Plasmids Encoding Complete GRA5, SAG1, and ROP2 Antigens of Toxoplasma gondii in BALB/C Mice
por: NASERIFAR, Razi, et al.
Publicado: (2015)

Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice
por: Liu, Yuan, et al.
Publicado: (2017)

Sequence Variation in Superoxide Dismutase Gene of Toxoplasma gondii among Various Isolates from Different Hosts and Geographical Regions
por: Wang, Shuai, et al.
Publicado: (2015)

Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice
por: Wu, Xiao-Nan, et al.
Publicado: (2012)

Production and Evaluation of Toxoplasma gondii Recombinant Surface Antigen 1 (SAG1) for Serodiagnosis of Acute and Chronic Toxoplasma Infection in Human Sera
por: Selseleh, M (Mina), et al.
Publicado: (2012)

Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1
por: Wang, Yanhua, et al.
Publicado: (2013)

Expression of in vivo biotinylated recombinant antigens SAG1 and SAG2A from Toxoplasma gondii for improved seroepidemiological bead-based multiplex assays
por: Klein, Sandra, et al.
Publicado: (2020)

Recombinant SAG1 Antigen to Detect Toxoplasma gondii Specific Immunoglobulin G in Human Sera by ELISA Test
por: Jalallou, N, et al.
Publicado: (2010)

Vaccination against Murine Toxoplasmosis Using Recombinant Toxoplasma gondii SAG3 Antigen Alone or in Combination with Quil A
por: Lee, Young-Ha, et al.
Publicado: (2007)

Evaluation of Recombinant SAG1, SAG2, and SAG3 Antigens for Serodiagnosis of Toxoplasmosis
por: Khanaliha, Khadijeh, et al.
Publicado: (2014)

Analysis of Structures and Epitopes of Surface Antigen Glycoproteins Expressed in Bradyzoites of Toxoplasma gondii
por: Cong, Hua, et al.
Publicado: (2013)

MOLECULAR CHARACTERIZATION AND SEQUENCE PHYLOGENETIC ANALYSIS OF SURFACE ANTIGEN 3 (SAG3) GENE OF LOCAL INDIAN ISOLATES (CHENNAI AND IZATNAGAR) OF Toxoplasma gondii
por: SUDAN, Vikrant, et al.
Publicado: (2015)

Primary structure of mature SAG1 gene of an Indonesian Toxoplasma gondii and comparison with other strains
por: Hartati, Sri, et al.
Publicado: (2006)

Toxoplasma gondii SAG2, SAG3 and GRA6 alleles and single nucleotide polymorphism in congenital infections with known parasite load and clinical outcome
por: Targa, Lília Spaleta, et al.
Publicado: (2023)

Application of Toxoplasma gondii-specific SAG1, GRA7 and BAG1 proteins in serodiagnosis of animal toxoplasmosis
por: Qi, Tongsheng, et al.
Publicado: (2022)

Evaluation of Recombinant SAG1 Protein for Detection of Toxoplasma gondii Specific Immunoglobulin M by ELISA Test
por: Jalallou, N, et al.
Publicado: (2012)

Enhancing the detection of Toxoplasma gondii via an anti-SAG1 scFv-alkaline phosphatase immunoconjugate
por: Hannachi, Emna, et al.
Publicado: (2019)

SAG3 Toxoplasma gondii cloning reveals unexpected fivefold infection in the blood of feral cats in the Mexican Caribbean
por: Valenzuela-Moreno, Luis Fernando, et al.
Publicado: (2022)

Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
por: Guo, Jingjing, et al.
Publicado: (2019)

Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses
por: Li, Yawen, et al.
Publicado: (2018)

Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice
por: Laguía-Becher, Melina, et al.
Publicado: (2010)

Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis
por: Choi, Won Hyung, et al.
Publicado: (2020)

Toxoplasma gondii SAG1 targeting host cell S100A6 for parasite invasion and host immunity
por: Zhou, Li-Juan, et al.
Publicado: (2021)

Toxoplasma gondii infection in humans in China
por: Zhou, Peng, et al.
Publicado: (2011)

In Silico Vaccine Design and Expression of the Multi-Component Protein Candidate against the Toxoplasma gondii Parasite from MIC13, GRA1, and SAG1 Antigens
por: Hosseininejad, Zahra, et al.
Publicado: (2023)

Brain Tissue Cysts in Infected Mice with RH-Strain of Toxoplasma gondii and Evaluation of BAG1 and SAG1 Genes Expression
por: Selseleh, Monavar, et al.
Publicado: (2013)

Boosting Mouse Defense against Lethal Toxoplasma gondii Infection with Full-Length and Soluble SAG1 Recombinant Protein
por: Li, Xiang, et al.
Publicado: (2023)

Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB/c mice
por: Mavi, Sara Ayazian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7cc66n45pe23bipo8rfgf1g672